Evidence map›Paper›PMID 29423041›Full record

ArticleOncotarget2018

Individual and combined effect of

Ausra Stumbryte, Zivile Gudleviciene, Gabrielis Kundrotas, Daiva Dabkeviciene, Agne Kunickaite, Saulius Cicenas

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ausra StumbryteBiobank, National Cancer Institute, LT-08660 Vilnius, Lithuania.
Zivile GudlevicieneBiobank, National Cancer Institute, LT-08660 Vilnius, Lithuania.
Gabrielis KundrotasBiobank, National Cancer Institute, LT-08660 Vilnius, Lithuania.
Daiva DabkevicieneInstitute of Biosciences, Vilnius University Life Sciences Center, LT-10257 Vilnius, Lithuania.
Agne KunickaiteDepartment of Human and Medical Genetics, Faculty of Medicine, Vilnius University, LT-08661 Vilnius, Lithuania.
Saulius CicenasDepartment of Thoracic Surgery and Oncology, National Cancer Institute, LT-08660 Vilnius, Lithuania.
National Cancer Institute · LTVilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer (LC) is the second common and with the highest mortality oncological disease. Specific biomarkers for its diagnostics, treatment, and prognosis are still under the investigations. Aim of our study was to evaluate the relationship between the polymorphisms of TP53 pathway genes

Indexed as

HPV phylogenetic linelung cancer prognostic markersmortality ratepatient survivalSNPs

Identifiers

PMID29423041
PMCPMC5790458
OpenAlexW2770935524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.